both studies and an extensive process of conducting intensively going on 4 years opening vast numbers of topic/replies in all forums has me awareness of factors suggesting that pwn are not inclined to addictive behavior. as this process, one not unlike a homicide detective thumbing through vast amounts of paperwork, avails me of enough specifics from so many anonymized posts to accurately assess much. I submit that the hypersoniac/narcoleptic community is almost absolutely berift of addictive risks. in fact this group tends to be remiss when physicians suggest schedule II treatment options even as they may turn out beneficial. my conclusion is that advisements and articles stressing the alleged addiction potential of these meds are most inappropriate insofar as they address our treatment alone, as opposed to also adhd patients, for example. also, these mediums are incorrect in any and all assertions along these lines.
pwn/hypersomniac community would do well were we to cooperatively produce substantive explainations of this, perhaps then creating advisements of our own distributable to professional communities involved in our healthcare. based upon minimal abilities left for such an effort as this leaves so many of us with, I find feasibility scant. nonetheless, discard of extracurricular concerns and group cohesion may produce impact as would be of great benefit to our numbers.
also, when encountering materials suggesting upsurp or contestation of authority, pwn often have 'sheep -like' inability to take into consideration such things. this suggests perhaps not a 'perfect candidates for enslavement' profile as the nature of our affliction means we do not have the energy for this sort of thing. yet if visibility can be clearly alingned in our view of the problem, there may be workable solutions.
my investigation lacks anything inculpatory yet a very solid 'prima facie' case reveals widespread significantly sub- optimal healthcare of our group exists, lagely due to errant dose criteria in the prescribing of wakefulness promoting medication to treat eds. this is to be found in manufacturers recommended maximums and AASM treatment options as advocated for by same. also, an absence of the least suspicion by and large that anything within all such treatment reference resources may be in need of adjustments.